Northern Trust’s Global Cord Blood Corporation CO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-31,579
Closed -$94.3K 4675
2023
Q1
$94.3K Hold
31,579
﹤0.01% 4097
2022
Q4
$94.3K Hold
31,579
﹤0.01% 4106
2022
Q3
$94K Sell
31,579
-975
-3% -$2.4K ﹤0.01% 4133
2022
Q2
$96K Buy
+32,554
New +$101K ﹤0.01% 4189
2021
Q2
Sell
-11,359
Closed -$52K 4692
2021
Q1
$52K Sell
11,359
-7,202
-39% -$31.2K ﹤0.01% 4379
2020
Q4
$68K Buy
18,561
+1,935
+12% +$7.43K ﹤0.01% 4193
2020
Q3
$59K Sell
16,626
-682
-4% -$2.36K ﹤0.01% 4084
2020
Q2
$54K Sell
17,308
-15,600
-47% -$45.3K ﹤0.01% 4048
2020
Q1
$104K Buy
32,908
+300
+0.9% +$1.31K ﹤0.01% 3809
2019
Q4
$163K Buy
32,608
+11,918
+58% +$56.9K ﹤0.01% 3842
2019
Q3
$100K Sell
20,690
-1,200
-5% -$6.29K ﹤0.01% 3928
2019
Q2
$127K Hold
21,890
﹤0.01% 3924
2019
Q1
$154K Buy
21,890
+580
+3% +$3.83K ﹤0.01% 3830
2018
Q4
$138K Buy
21,310
+168
+0.8% +$1.07K ﹤0.01% 3862
2018
Q3
$148K Buy
+21,142
New +$159K ﹤0.01% 3936

Other funds holding CO

Northern Trust's CO Position: Q2 2023 in Review

Northern Trust sold out of Global Cord Blood Corporation (CO) in Q2 2023, closing a stake of 31,579 shares — an estimated $94.3K sold.

Northern Trust first reported a position in CO in Q3 2018 and held it in 15 quarters. The position peaked at $163K in Q4 2019. 6 funds tracked by Wall St. Rank hold CO as of Q2 2023.

  • Northern Trust reported no remaining Global Cord Blood Corporation position as of Q2 2023 after selling out during the quarter.
  • Northern Trust sold 31,579 Global Cord Blood Corporation shares in Q2 2023, an estimated $94.3K.
  • Northern Trust first reported a position in Global Cord Blood Corporation in Q3 2018 and held it in 15 quarters.
  • Northern Trust's Global Cord Blood Corporation position peaked at $163K in Q4 2019.
  • 6 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q2 2023.

Based on Northern Trust's 13F filing for Q2 2023, filed 11 Aug 2023.